IS7744A - Eikósapentanó sýra (EPA) til notkunar við meðhöndlun á lystarstoli (AN) og matgræðgi - Google Patents

Eikósapentanó sýra (EPA) til notkunar við meðhöndlun á lystarstoli (AN) og matgræðgi

Info

Publication number
IS7744A
IS7744A IS7744A IS7744A IS7744A IS 7744 A IS7744 A IS 7744A IS 7744 A IS7744 A IS 7744A IS 7744 A IS7744 A IS 7744A IS 7744 A IS7744 A IS 7744A
Authority
IS
Iceland
Prior art keywords
anorexia
epa
graft
treatment
eicosapentanoic acid
Prior art date
Application number
IS7744A
Other languages
English (en)
Inventor
Frederick Horrobin David (l βtinn)
Ayton Agnes
Original Assignee
Amarin Neuroscience Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9944164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS7744(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amarin Neuroscience Limited filed Critical Amarin Neuroscience Limited
Publication of IS7744A publication Critical patent/IS7744A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
IS7744A 2002-09-16 2005-03-15 Eikósapentanó sýra (EPA) til notkunar við meðhöndlun á lystarstoli (AN) og matgræðgi IS7744A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0221480.7A GB0221480D0 (en) 2002-09-16 2002-09-16 Treatment of anorexia nervosa (AN) and bulimia
PCT/GB2003/003985 WO2004024136A1 (en) 2002-09-16 2003-09-16 Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia

Publications (1)

Publication Number Publication Date
IS7744A true IS7744A (is) 2005-03-15

Family

ID=9944164

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7744A IS7744A (is) 2002-09-16 2005-03-15 Eikósapentanó sýra (EPA) til notkunar við meðhöndlun á lystarstoli (AN) og matgræðgi

Country Status (20)

Country Link
US (1) US20060135608A1 (is)
EP (1) EP1556028A1 (is)
JP (1) JP2006503031A (is)
KR (1) KR20050042823A (is)
CN (1) CN1694694A (is)
AU (1) AU2003269138A1 (is)
BR (1) BR0317857A (is)
CA (1) CA2499142A1 (is)
GB (1) GB0221480D0 (is)
HR (1) HRP20050245A2 (is)
IS (1) IS7744A (is)
MX (1) MXPA05002943A (is)
NO (1) NO20051847L (is)
NZ (1) NZ538793A (is)
PL (1) PL375726A1 (is)
RS (1) RS20050226A (is)
RU (1) RU2330653C2 (is)
TW (1) TW200410682A (is)
WO (1) WO2004024136A1 (is)
ZA (1) ZA200502161B (is)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003048831A (ja) 2001-08-02 2003-02-21 Suntory Ltd 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物
WO2005046668A1 (ja) * 2003-11-14 2005-05-26 Mochida Pharmaceutical Co., Ltd. 言語障害予防・治療剤
JP4993852B2 (ja) 2004-09-17 2012-08-08 サントリーホールディングス株式会社 ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物
JP5967855B2 (ja) 2005-06-30 2016-08-10 サントリーホールディングス株式会社 日中活動量の低下および／又はうつ症状の改善作用を有する組成物
WO2008081989A1 (ja) 2006-12-28 2008-07-10 Suntory Holdings Limited 神経再生剤
US8816110B2 (en) 2007-02-15 2014-08-26 Scf Pharma Inc. Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
DK2121576T3 (en) 2007-02-15 2016-02-15 Ct De Rech Sur Les Biotechnologies Marine Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
WO2008113177A1 (en) 2007-03-20 2008-09-25 Centre De Recherche Sur Les Biotechnologies Marines Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
US8455472B2 (en) * 2009-06-15 2013-06-04 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
KR20140007430A (ko) * 2011-02-11 2014-01-17 이 아이 듀폰 디 네모아 앤드 캄파니 에이코사펜타엔산 농축물
US9447020B2 (en) 2013-10-31 2016-09-20 Scf Pharma Inc. Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
RU2545988C1 (ru) * 2013-11-12 2015-04-10 Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр Департамента здравоохранения города Москвы Способ лечения хронического запора и функциональной анорексии
CN111971041A (zh) 2018-02-07 2020-11-20 Scf制药股份有限公司 多不饱和脂肪酸单甘油酯、组合物、方法及其用途
WO2019204218A1 (en) * 2018-04-16 2019-10-24 Quadrant Biosciences Inc. Salivary microrna levels in anorexia nervosa provide a liquid biopsy of metabolic and neuropsychiatric status
AU2019264159A1 (en) 2018-05-03 2020-12-24 Scf Pharma Inc. Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof
CN109276262B (zh) * 2018-07-30 2021-01-26 中国科学院心理研究所 一种用于筛选高危进食障碍的检测系统
US20210299065A1 (en) * 2020-03-27 2021-09-30 Homeostasis Therapeutics, Limited Methods of treatment for anorexia nervosa, bulimia and related clinical syndromes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
GB9901809D0 (en) * 1999-01-27 1999-03-17 Scarista Limited Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes

Also Published As

Publication number Publication date
RU2330653C2 (ru) 2008-08-10
JP2006503031A (ja) 2006-01-26
GB0221480D0 (en) 2002-10-23
WO2004024136A1 (en) 2004-03-25
ZA200502161B (en) 2005-09-15
RS20050226A (en) 2007-09-21
RU2005107416A (ru) 2006-01-20
CA2499142A1 (en) 2004-03-25
HRP20050245A2 (en) 2005-10-31
CN1694694A (zh) 2005-11-09
BR0317857A (pt) 2005-12-06
PL375726A1 (en) 2005-12-12
TW200410682A (en) 2004-07-01
EP1556028A1 (en) 2005-07-27
US20060135608A1 (en) 2006-06-22
AU2003269138A1 (en) 2004-04-30
NZ538793A (en) 2007-05-31
MXPA05002943A (es) 2005-06-03
NO20051847L (no) 2005-04-15
KR20050042823A (ko) 2005-05-10

Similar Documents

Publication Publication Date Title
IS7744A (is) Eikósapentanó sýra (EPA) til notkunar við meðhöndlun á lystarstoli (AN) og matgræðgi
NO20034430D0 (no) Tiohydantoiner og anvendelse derav for behandling av diatbetes
IS8267A (is) [1,8]naftýridín-2-ón og tengd efnasambönd til notkunar við meðferð á geðklofa
IS2964B (is) Beta-amínó tetrahýdróimídasó(1,2-a)pýrasín og tetrahýdrótríasóló(4,3-a)pýrasín til nota í meðhöndlun á sykursýki af gerð II
NO20052139L (no) Bandasje og epidermal posisjoneringsmekanisme og fremgangsmate for anvendelse av samme
DK2423335T3 (da) Kimæriske immunmodulatoriske forbindelser og fremgangsmåder til anvendelse deraf
NO20022286D0 (no) Fasesementeringsverktöy for tynne hull og fremgangsmåte
IS7858A (is) Samsetning til notkunar í meðferð á athyglisbresti með ofvirkni (ADHD)
IS8071A (is) Aðferð við meðhöndlun á hnútahersli, fitudreyra og tengdum ástands tegundum og lyfjafræðilegum samsetningum
EE05015B1 (et) Makseterminaliseade mgipunktiseadme hendamiseks, maksessteem ja makseprotseduuri teostamise meetod
NO20012689D0 (no) Nye fluider og teknikker for matriks syrebehandling
TWI341551B (en) Stage apparatus and light exposing apparatus
DK1216342T3 (da) Undervandssmöreapparat og fremgangsmåder til at cirkulere fluider i et undervandssmöreapparat
DK1375647T3 (da) Kunstig dermis og fremstillingsfremgangsmåde dertil
NO20042700L (no) Kraftforsyningssystem og elektronisk innretning som omfatter systemet
IS7348A (is) N-pýrasínýl-fenýlsúlfónamíð og notkun þeirra til að meðhöndla flakkboðatengda sjúkdóma
IS8497A (is) Aðferðir og hvarfefni til að meðhöndla bólgusjúkdóma
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
ITTO20001156A0 (it) Apparecchiatura per il trattamento di disgregazione di campioni biologici e dispositivo disgregatore per l'impiego in detta apparecchiatura.
NO20020860L (no) Betalingskort og tilhörende fremgangsmåte
ITTO20010848A0 (it) Disposizione e metodo di purificazione o trattamento elettrochimico.
IS7962A (is) Þíenópýridasínón og notkun þeirra í breytingu á sjálfsnæmissjúkdómi
IS7275A (is) Samsetning fyrir hollegg og notkun á henni
IS7868A (is) Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.
DK1530462T3 (da) 1-phenyl-2-dimethylaminomethylcyclohexanforbindelser til behandling af depressionssymtomer. smerte og inkontinens